Crohn's disease and Ulcerative Colitis and indeterminate Colitis K50-K51
Conditions
Interventions
Group 1: Observational study in adult patients with IBD (Inflammatory Bowel Disease). Observation period: 10 years and more. Data collected includes quality of life (PROM-10, sIBDQ, Facit-F, bowel urg
Sponsors
ImmunoRegister gGmbH
Eligibility
Sex/Gender
All
Age
16 Years to No maximum
Inclusion criteria
Inclusion criteria: Crohn's disease, Ulcerative Colitis or Indeterminate Colitis
Exclusion criteria
Exclusion criteria: Gastrointestinal disorders other than those mentioned above
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessment and Improvement of quality of care for IBD patients Parameter: oCDAI (Crohn's disease activity index) oMayo Score / partial Mayo Score (Ulcerative Colitis) oSES-CD Score (Simple Endoscopic Score for Crohn's disease) osIBDQ (short Inflammatory Bowel Disease Quality of Life) oBowel urgency scale (Lilly) oFACIT-F (Functional Assessment of Chronic Illness Therapy - Fatigue) oPROMIS-10 (Patient Related Outcome Measure Information System -10-item) Visit frequency according to clinical practice (approx. every 3 months) | — |
Secondary
| Measure | Time frame |
|---|---|
| • Long-term effectiveness of treatment with IBD therapies, e.g. drug persistence, effectiveness/side effects of treatment (-combinations), level of disease activity achieved • Assessment of incidence and prevalence of IBD • Real life Treatment costs / Pharmacoeconomic costs | — |
Countries
Germany
Contacts
Public ContactStefanie Howaldt
ImmunoRegister gGmbH
Outcome results
None listed